From owner-chemistry@ccl.net Thu Feb 8 11:10:01 2018 From: "Dorine Vidal dvidal]~[chemcomp.com" To: CCL Subject: CCL: Announcement - Chemical Computing Group releases MOE 2018.01 Message-Id: <-53172-180208104644-23872-pXn/U8kCPHb06EGaeoAIZg,,server.ccl.net> X-Original-From: "Dorine Vidal" Content-Language: en-us Content-Type: multipart/mixed; boundary="----=_NextPart_000_347D_01D3A0CA.169F4150" Date: Thu, 8 Feb 2018 10:46:33 -0500 MIME-Version: 1.0 Sent to CCL by: "Dorine Vidal" [dvidal ~~ chemcomp.com] This is a multipart message in MIME format. ------=_NextPart_000_347D_01D3A0CA.169F4150 Content-Type: multipart/alternative; boundary="----=_NextPart_001_347E_01D3A0CA.169F4150" ------=_NextPart_001_347E_01D3A0CA.169F4150 Content-Type: text/plain; charset="US-ASCII" Hello, CCG is pleased to announce the 2018.01 version of MOE. I have attached a short announcement in html. Could you please post it on your website. If not, let me know how to proceed? Many thanks in advance! Cheers, Dorine Vidal Marketing Communications Manager Chemical Computing Group | chemcomp.com dvidal_+_chemcomp.com | + 1 (514) 393-1055 -- ------------------------------ Chemical Computing Group | www.chemcomp.com | 910-1010 Sherbrooke W., Montreal QC H3A 2R7, Canada | +1 514 393 1055 Manage Communications: www.chemcomp.com/Manage_Subscription.htm ------=_NextPart_001_347E_01D3A0CA.169F4150 Content-Type: text/html; charset="ISO-8859-1" Content-Transfer-Encoding: quoted-printable

Hello,

CCG is pleased to announce the 2018.01 ve= rsion of MOE.

I have attached a short an= nouncement in html.

Could you please po= st it on your website. If not, let me know how to proceed?

Many thanks in advance!

Cheers,

 

= Dorine Vidal=

Marketing Communications Manager

Chemical Co= mputing Group | chemcomp.com

<= span lang=3DEN-CA style=3D'font-size:10.0pt'>dvidal_+_chemcomp.com | + 1 (514) 393-1055

 



Chemical Computing Group | www.chemcomp.com=A0| 910= -1010 Sherbrooke W., Montreal QC H3A 2R7, Canada |=A0+1 514 393 1055
Manage Communications
:=A0w= ww.chemcomp.com/Manage_Subscription.htm
------=_NextPart_001_347E_01D3A0CA.169F4150-- ------=_NextPart_000_347D_01D3A0CA.169F4150 Content-Type: text/html; name="CCL_Press.release_MOE.2018.01.htm" Content-Transfer-Encoding: quoted-printable Content-Disposition: attachment; filename="CCL_Press.release_MOE.2018.01.htm"

CCL announcement: MOE 2018.01

 

Subject line: CCG releases MOE 2018.01

 

We are pleased to = announce the 2018 release of the Molecular Operating Environment (MOE). The 2018.01 = version of MOE introduces new capabilities with the development of applications for performing torsion scans and analyses, modeling natural and synthetic polynucleotide systems, predicting protein-protein binding sites, and calculating R-group contributions to molecular = properties through MOEsaic. Additional features in MOE 2018.01 include a = redesigned Antibody Modeler for high throughput model building, a new MOE Project = database containing T-Cell Receptor (TCR) - Major Histocompatibility Complex = (MHC) crystal structures, enhancements to VCD spectral analysis, MOE graphical = and UI enhancements, and support for HP zSpace = immersive virtual holographic 3D visualization.

 

To request a free trial of MOE = 2018.01 or for additional information, please contact: Raul Alvarez, Senior Manager, Marketing Strategy, ralvarez_+_chemcomp.com

 

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D

NEW = & ENHANCED FEATURES IN MOE 2018.01

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

* Epitope Mapping and Analysis

* RNA/DNA = Builder

* Torsion Scanning and = Analysis

* MOEsaic =96 SAR = and MMP Analysis

* Unified Molecular Dynamics Interface to = AMBER

* MOE/web = enhancements

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D= =3D=3D=3D=3D=3D=3D=3D

 

Key = application areas in MOE: http://www.chemcomp.com/index.htm

Structure-Ba= sed Design - Fragment-Based Design - Pharmacophore Discovery - Medicinal = Chemistry Applications - Biologics Applications - Protein and Antibody Modeling - = Molecular Modeling and Simulations - Cheminformatics & QSAR =96 Methods = Development and Deployment

 

 

Raul Alvarez

Senior Manager, Marketing = Strategy

Chemical Computing Group

T. + 1 = (514) 393-1055 | F. +1 (514) 874-9538

ralvarez_+_chemcomp.com | www.chemcomp.com

------=_NextPart_000_347D_01D3A0CA.169F4150-- From owner-chemistry@ccl.net Thu Feb 8 13:04:00 2018 From: "Hansmann, Ulrich H. uhansmann[A]ou.edu" To: CCL Subject: CCL: Workshop announcement: CBSB2018, Shenzhen, China, May 20-23,2018 Message-Id: <-53173-180208121607-12713-P8a5B09yXquyQLRMJe2n+A[*]server.ccl.net> X-Original-From: "Hansmann, Ulrich H." Content-ID: Content-Language: en-US Content-Transfer-Encoding: 8bit Content-Type: text/plain; charset="utf-8" Date: Thu, 8 Feb 2018 17:15:53 +0000 MIME-Version: 1.0 Sent to CCL by: "Hansmann, Ulrich H." [uhansmann(_)ou.edu] Dear Colleague, we invite you to participate in the upcoming workshop on biological physics and systems biology entitled "From Computational Biophysics to Systems Biology 2018 (CBSB2018)” (http://hpcc.siat.ac.cn/cbsb/cbsb.html) which will be organized by the Shenzhen Institutes for Advanced Technologies (Chinese Academy of Sciences), and will take place in Shenzhen, China, on May 20-23, 2018. * There are opportunities for oral presentations, and * * students/postdocs are eligible for travel fellowships. * * More details can be found below or at below or the webpage. * CBSB2018 is organized in conjunction with Shenzhen Institutes for Advanced Technologies and the University of Oklahoma, and it will continue a series of successful workshops that have been held since 2006 in both Europe and the USA. As in previous years, the workshop aims to bring together expertise from physics, biology, and computer science to discuss current trends in computational biophysics and systems biology. Topics of CBSB2018 will include folding and aggregation, protein-protein complexes, supra-molecular assemblies, cellular environments and interaction networks. Keynote Speakers will be: * Jiali Gao (University of Minnesota) * Depei Qian (Sun Yat-Sen University) A list of confirmed invited speakers includes: * Jun Fan (City University of Hongkong) * Wei Han (Peking University Shenzhen Graduate School) * Xuhui Huang (Hongkong University of Science and Technology) * Fan Jiang (Peking University Shenzhen Graduate School) * Parimal Kar (Indian Institute of Technology, Indore) * Ly Le (Hi Chi Minh City International University) * Guohui Li (Dalian Institute of Chemical Physics, Chinese Academy of Sciences) * Jianing Li (University of Vermont) * Kei Moritsugu (Yokohama City University) * Yuguang Mu (NanYang Technological University, Singapor) * Hongbin Shen (Shanghai Jiaotong University) * Guanghong Wei (Fudan University) * Dongqing Wei (Shanghai Jiaotong University) We especially encourage participation by students and postdocs, and we expect to offer financial support for selected students and postdocs on a competitive basis. Five junior scientists (students and postdocs) will be selected to receive a "CBSB2018 Young Researcher Award" which we expect to include a 1000 RMB ($150) stipend and the opportunity to give a featured oral presentation. Awardees will also be exempt from the registration fee. Contingent on availability of funds, additional junior scientists may receive travel awards and free registration. Note that oral presentation slots (Contributed Talks) are reserved primarily to students, postdocs and other researchers at an early stage of their career, and will be assigned on a competitive basis. In addition, research can be presented in poster form. The registration deadline is April 15 to be considered for an oral or poster presentation. Acceptance letters and notifications of fellowship awards will be sent out by April 28, 2018. The registration fee is 1000 RMB ($150) for faculty/staff, and 700 RMB ($110) for students and Postdocs, for registrations before 15 April 2018. For registrations received after that day, the fee is 1200 RMB ($190) for faculty/staff, and 900 RMB ($140) for students and postdocs. Please circulate this announcement among your colleagues, students, and postdocs; and contact us with any questions you might have by sending email to cbsb18-#-siat.ac.cn. With best regards, Ulrich H.E. Hansmann Shengzhong Feng Yanjie Wei Ulrich H.E. Hansmann Twitter: -#-HansmannLab www.hansmann-lab.com From owner-chemistry@ccl.net Thu Feb 8 22:04:00 2018 From: "=?UTF-8?Q?Abdurrahman_OL=C4=9EA=C3=87?= aolgac|,|evias.com.tr" To: CCL Subject: CCL: 22nd European Symposium on Quantitative Structure-Activity Relationship (EuroQSAR2018) Message-Id: <-53174-180208154903-5836-rTEd6iMaa+auc+9fsk6PFw,server.ccl.net> X-Original-From: =?UTF-8?Q?Abdurrahman_OL=C4=9EA=C3=87?= Content-Type: multipart/alternative; boundary="001a1143be4c73020c0564b98ac6" Date: Thu, 8 Feb 2018 23:48:37 +0300 MIME-Version: 1.0 Sent to CCL by: =?UTF-8?Q?Abdurrahman_OL=C4=9EA=C3=87?= [aolgac-x-evias.com.tr] --001a1143be4c73020c0564b98ac6 Content-Type: text/plain; charset="UTF-8" Content-Transfer-Encoding: quoted-printable Dear colleagues, The 22nd EuroQSAR 2018 symposium, entitled =E2=80=9CTranslational and Healt= h Informatics: Implications for Drug Discovery=E2=80=9D, will take place on S= eptember 16-20, 2018 in Thessaloniki, Greece. We would like to inform you that the registrations and abstract submissions are open. The early-bird symposium registration deadline is May 31, 2018. The European Quantitative Structure-Activity Relationships (EuroQSAR) Symposia are major scientific events that have been organized in different cities of Europe since 1973. They have the fascinating scope to promote and disseminate advances in rational approaches in drug design and discovery with a worldwide attendance of prominent scientists from both academia and industry. The scientific program of the symposium will include plenary lectures, keynote lectures, oral communications, workshops, poster presentations and a commercial exhibition. The symposium will take place in Thessaloniki, a cozy and cosmopolitan European city, which integrates the art, history and cuisine of ancient Greek, Byzantine, Ottoman, and Jewish cultures. For more details, registration and abstract submission please visit http://www.euroqsar2018.org And if you have any questions please don't hesitate to contact with Symposium Secretariat ( info*euroqsar2018.org ) See you in Thessaloniki! EuroQSAR 2018 Organization Committee *Abdurrahman Ol=C4=9Fa=C3=A7*, PhD CEO & Founder *Evias Pharmaceutical R&D Ltd.* * Tel: +90 312 920 0270 Fax: +90 312 920 0271 * *Address:* Gazi =C3=9Cniversitesi G=C3=B6lba=C5=9F=C4=B1 Yerle=C5=9Fkesi Teknoplaza Binas=C4=B1 G1 101 Zip Code: 06830 G=C3=B6lba=C5=9F=C4=B1, Ankara, Turkey *Web:* http://www.evias.com.tr --001a1143be4c73020c0564b98ac6 Content-Type: text/html; charset="UTF-8" Content-Transfer-Encoding: quoted-printable
Dear colleague= s,

The 22nd EuroQSAR 2018 symposium, entitled= =E2=80=9CTranslational and Health Informatics: Implications for Drug Disco= very=E2=80=9D, will take place on September 16-20, 2018 in Thessaloniki, Gr= eece.

We would like to inform you that the registr= ations and abstract submissions are open.
The early-bird symposiu= m registration deadline is May 31, 2018.

The European Quantitative Structure-Activity Rela= tionships (EuroQSAR) Symposia are major scientific events that have been or= ganized in different cities of Europe since 1973. They have the fascinating= scope to promote and disseminate advances in rational approaches in drug d= esign and discovery with a worldwide attendance of prominent scientists fro= m both academia and industry.

The scientific program of the symposium = will include plenary lectures, keynote lectures, oral communications, works= hops, poster presentations and a commercial exhibition.

The symposium will take place in Thessaloniki, a cozy and cosmopolita= n European city, which integrates the art, histor= y and cuisine=C2=A0of ancient Greek, Byzantine,=20 Ottoman, and Jewish cultures.

And if you have any que= stions please don't hesitate to contact with Symposium Secretariat ( info*euroqsar2018.org )

See you in=20 Thessaloniki!

EuroQSAR 2018 Organ= ization Committee

Abdurrah= man Ol=C4=9Fa=C3=A7, PhD
CEO=C2=A0&=C2=A0Founder
Evias Pharmaceutical R&D Ltd.=
= Tel:=C2=A0=C2=A0+90 312 920 0270 =C2=A0Fax:=C2=A0+90 312 920 0271
Address:=C2=A0Gazi =C3=9Cniversitesi G=C3=B6lba=C5=9F=C4=B1 Yerle=C5=9Fkesi=
Teknoplaza Binas=C4=B1 G1 101=C2=A0<= /font>Zip Code: 06830<= /span>
G=C3= =B6lba=C5=9F=C4=B1, Ankara, Turkey
--001a1143be4c73020c0564b98ac6--